catalyst

Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Ad — primary completion

as of 2026-07-01
at a glance
2023-11-08 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Ad — primary completion
Type
Trial Readout
Date
2023-11-08
Date type
ACTUAL
Phase
Phase 3
This event happened.